Product Overview
Tesamorelin + Ipamorelin Two-Component Secretagogue Research Blend
High-quality Tesamorelin + Ipamorelin two-component secretagogue research blend for growth hormone & secretagogues and laboratory analytical research
Tesamorelin + Ipamorelin is supplied as a two-component secretagogue research blend for qualified laboratory research in growth-hormone-releasing hormone pathways, ghrelin-receptor signalling, secretagogue assays, peptide characterisation and analytical method development. Available specifications: 15 mg × 10 vials. The exact composition, concentration and release method must be confirmed on the batch COA before publication. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Synonym(s): Tesamorelin and Ipamorelin research blend
Packaging & Availability
Pricing is supplied on request. Select one or more pack sizes to add them to your quote cart.
| Select | SKU | Pack Size | Availability | Price |
|---|---|---|---|---|
| TSM+IP | 15mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request |
Product Overview
Tesamorelin + Ipamorelin is supplied as a two-component secretagogue research blend for qualified research organisations, analytical laboratories and product-development teams. It is positioned for growth-hormone-releasing hormone pathways, ghrelin-receptor signalling, secretagogue assays, peptide characterisation and analytical method development. The final website specification must match the released batch COA and SDS.
Key Features
- Product type: Two-Component Secretagogue Research Blend
- Available specifications: 15 mg × 10 vials
- Purity / quality: Composition, component identity, concentration and assay/purity must be stated on the batch COA
- Appearance: White to off-white lyophilized powder; confirm against the batch COA
- Quality documentation: batch COA, HPLC or potency assay, MS where applicable, SDS and specification sheet
- Bulk supply and custom labelling are subject to technical, quality and compliance review
- The verified composition, concentration, total content and analytical release method must be shown on the batch COA
Research Applications
Typical non-clinical research use includes growth-hormone-releasing hormone pathways, ghrelin-receptor signalling, secretagogue assays, peptide characterisation and analytical method development, chromatographic method development, mass-spectrometric or potency confirmation, stability assessment, formulation compatibility and raw-material quality control. The purchaser is responsible for validating suitability in the intended protocol.
Quality & Supply
Batch-specific documentation is available according to the selected grade and order. State the required content, quantity, assay/purity, destination country, packaging format and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Tesamorelin + Ipamorelin?
Tesamorelin + Ipamorelin is supplied as a two-component secretagogue research blend for qualified laboratory research.
What specifications are available?
Current catalogue specifications are 15 mg × 10 vials. Final availability must be confirmed when requesting a quotation.
How is the formulation or component ratio confirmed?
The full composition, component concentrations, ratio, total content and analytical release method must be stated on the batch COA before publication.
What purity or quality is supplied?
Composition, component identity, concentration and assay/purity must be stated on the batch COA. The released batch COA is the controlling quality record.
Which quality documents are available?
Batch COA, HPLC or potency-assay results, MS where applicable, SDS and a specification sheet may be available depending on the product and batch.
How should Tesamorelin + Ipamorelin be stored?
Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles.
Is Tesamorelin + Ipamorelin intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Product Properties
| Product Name | Tesamorelin + Ipamorelin |
|---|---|
| Product Type | Two-Component Secretagogue Research Blend |
| Main Category | Performance Peptides |
| Subcategory | Growth Hormone & Secretagogues |
| Available Specifications | 15 mg × 10 vials |
| Purity / Quality | Composition, component identity, concentration and assay/purity must be stated on the batch COA |
| Appearance | White to off-white lyophilized powder; confirm against the batch COA |
| Storage | Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles. |
| Quality Documents | Batch COA; HPLC or potency assay; MS where applicable; SDS; specification sheet |
Analytical & Research Scope
Tesamorelin + Ipamorelin may be evaluated in growth-hormone-releasing hormone pathways, ghrelin-receptor signalling, secretagogue assays, peptide characterisation and analytical method development. Final method suitability, acceptance criteria and regulatory classification must be established by the purchaser.
Ordering Information
Specify the required content, quantity, assay/purity, packaging format, destination and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
- Read the batch-specific Safety Data Sheet and product specification before handling.
- Use suitable laboratory gloves, protective clothing and eye protection.
- Avoid inhalation, ingestion and direct contact with skin or eyes.
- Use only in a controlled laboratory environment with appropriate engineering controls.
- Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles.
- Confirm the identity, concentration and ratio of every component before any analytical work.
- Dispose of unused material, solutions and packaging according to institutional and local requirements.
No clinical dosing, treatment or consumer-use information is provided.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.